Evidence map›Paper›PMID 33191253›Full record

ArticleBMJ open2020

Vascular and metabolic risk factor differences prior to dementia diagnosis: a multidatabase case-control study using European electronic health records.

Gayan Perera, P R Rijnbeek, Myriam Alexander, David Ansell, Paul Avillach, Talita Duarte-Salles, Mark Forrest Gordon, Francesco Lapi, Miguel Angel Mayer, Alessandro Pasqua and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Modern sources of controls in case-control studies.American journal of epidemiology · 2025
    Article
  2. Article
  3. The Role of Hypertension in Cognitive Dysfunction.Journal of clinical medicine · 2024
    Review
  4. Article
  5. Article
  6. Artificial intelligence for dementia prevention.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 7 countries.

Gayan PereraPsychological Medicine, King's College London (Institute of Psychiatry, Psychology and Neuroscience), London, UK.ORCID 0000-0002-3414-303X
P R RijnbeekDepartment of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.
Myriam AlexanderQuantitative Sciences, GlaxoSmithKline Plc, Brentford, UK.
David AnsellInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Paul AvillachDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Talita Duarte-SallesIDIAP Jordi Gol, Barcelona, Spain.ORCID 0000-0002-8274-0357
Mark Forrest GordonSpecialty Clinical Development, Neurology and Psychiatry, Teva Pharmaceuticals USA Inc, North Wales, Pennsylvania, USA.
Francesco LapiHealth Search, Italian College of General Practitioners and Primary Care, Florence, Italy.
Miguel Angel MayerHospital del Mar Institute for Medical Research, Barcelona, Spain.
Alessandro PasquaHealth Search, Italian College of General Practitioners and Primary Care, Florence, Italy.
Lars PedersenDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Johan van Der LeiDepartment of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.
Pieter Jelle VisserDepartment of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands.
Robert StewartPsychological Medicine, King's College London (Institute of Psychiatry, Psychology and Neuroscience), London, UK robert.stewart@kcl.ac.uk.
Erasmus MC · NLKing's College London · GBSocietà Italiana di Medicina Generale · ITAarhus University Hospital · DKGlaxoSmithKline (United Kingdom) · GBHarvard University · USHospital Del Mar · ESInstitut Universitari d'Investigació en Atenció Primària Jordi Gol · ESKarolinska Institutet · SETeva Pharmaceuticals (United States) · USUniversity of Birmingham · GB

Funding

Medical Research Council MC_PC_17214Medical Research Council MR/T045302/1
6 · The paper itself

Abstract

objectiveThe objective of the study is to compare body mass index (BMI), systolic/diastolic blood pressure (SBP/DBP) and serum total cholesterol levels between dementia cases and controls at multiple time intervals prior to dementia onset, and to test time interval as a modifying factor for these associations.

designCase-control study.

settingSix European electronic health records databases.

participants291 780 cases at the date of first-recorded dementia diagnosis, compared with 29 170 549 controls randomly selected from the same databases, age matched and sex matched at this index date. EXPOSURE: The following measures were extracted whenever recorded within each dataset: BMI (kg/m MAIN OUTCOMES: Case-control differences in exposures of interest were modelled for each time period and adjusted for demographic and clinical factors (ischaemic/unspecified stroke, type 2 diabetes mellitus, acute myocardial infarction, hypertension diagnosis, antihypertensive medication, cholesterol-lowering medication). Coefficients and interactions with time period were meta-analysed across the six databases.

resultsMean BMI (coefficient -1.16 kg/m

conclusionRoutine clinical data show emerging divergence in levels of BMI and SBP prior to the diagnosis of dementia but less evidence for DBP or total cholesterol levels. These divergences should receive at least some consideration in routine dementia risk screening, although underlying mechanisms still require further investigation.

Indexed as

DementiaAgedAged, 80 and overBlood PressureCase-Control StudiesDiabetes Mellitus, Type 2Electronic Health RecordsFemaleHumansHypertensionMaleRisk Factorsdementiaepidemiologyhealth informaticshypertensionmental healthphysiology

Identifiers

PMID33191253
PMCPMC7668358
OpenAlexW3103048034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.